Uterine leiomyosarcoma: A review of the literature and update on management options

Gynecologic Oncology
Maureen E RobertsChristina S Chu

Abstract

Uterine leiomyosarcoma is the most common type of uterine sarcoma. It is an extremely aggressive malignancy associated with a poor overall prognosis. Women affected may vary in age, but are most often diagnosed in their perimenopausal years. Presenting symptoms may be vague and mimic other benign uterine conditions. Preoperative diagnosis of leiomyosarcoma is difficult and often only made at time of surgical resection. These rare mesenchymal tumors are characterized by cytologic atypia, a high mitotic index, and tumor necrosis on histologic inspection. Management of early stage disease entails hysterectomy and complete surgical resection of gross tumor, though routine oophorectomy or lymph node dissection do not appear to confer much clinical benefit. Adjuvant therapy for early stage disease remains controversial as multiple clinical trials have failed to demonstrate benefit on overall survival. Recently, progress has been made in regards to therapy for advanced and recurrent disease. Novel chemotherapeutics, targeted therapies such as olaratumab and pazopanib, and new immunotherapies such as nivolumab and pembrolizumab have demonstrated promise in these previously difficult drug-resistant patients. In this article, we provide ...Continue Reading

Citations

Aug 10, 2019·Hormone Molecular Biology and Clinical Investigation·Mohamad Nasir ShafieeNirmala Kampan
Nov 21, 2019·Cells·Bruna Cristine de AlmeidaKatia Candido Carvalho
Dec 7, 2019·Journal of Surgical Case Reports·Kazuomi SuzukiMasakazu Yamamoto
Dec 14, 2019·Menopause : the Journal of the North American Menopause Society·Mara UlinQiwei Yang
Feb 19, 2020·Current Oncology Reports·Michelle LightfootKristin Bixel
May 16, 2020·Climacteric : the Journal of the International Menopause Society·S G VitaleS Cianci
Aug 9, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J GooteeP Silberstein
Aug 17, 2019·World Journal of Clinical Cases·Alessandro RizzoMargherita Nannini
Aug 8, 2019·International Journal of Molecular Sciences·Dana DvorskáZuzana Danková
Aug 7, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Katherine CotangcoM Patrick Lowe
Aug 6, 2020·Cancers·Annalisa AstolfiMaria Abbondanza Pantaleo
Dec 18, 2020·Journal of Surgical Oncology·Koji MatsuoLynda D Roman
Dec 5, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sabrina CroceFrédéric Chibon
Sep 30, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gabriella FerrandinaDomenica Lorusso
Oct 23, 2020·Indian Journal of Surgical Oncology·Sumit KumarRitesh Kumar
Oct 17, 2020·Annals of Surgical Oncology·Koji MatsuoLynda D Roman
Jun 21, 2020·Pathology·Hemamali SamaratungaLars Egevad
Mar 23, 2021·Gynecologic Oncology Reports·Maya YasukawaPaul H Sugarbaker
Jun 3, 2021·Abdominal Radiology·Jyothi P JagannathanFiona M Fennessy
Oct 17, 2020·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Jordan D LeGoutLauren F Alexander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.